Home » Authors » Lynn Yoffee

Lynn Yoffee

lynn.yoffee@clarivate.com

Articles

ARTICLES

Volcano's integrated imaging paints clearer lesion picture

April 17, 2008

Newly downsized St. Jude Eon all charged up for back pain

April 16, 2008

Paracor's HeartNet offers a 'hug,' and an option, for failing hearts

April 14, 2008

Volcano's integrated imaging paints clearer lesion picture

April 11, 2008

Gen-Probe starts pivotal trial for new assay to detect HPV

April 10, 2008

ArthroCare Cavity SpineWand bolsters cancer-fighting toolkit

April 9, 2008

Gen-Probe starts pivotal trial for new assay to detect HPV

April 7, 2008

ICD market may expand on news from REVERSE trial

April 4, 2008

Medtronic to pursue CRT use for mild heart failure patients

April 3, 2008

New polymer-free DES, with 60% less drug, effective in patients

April 2, 2008

View All Articles by Lynn Yoffee

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 2, 2025
Ionis notches Arrowhead win; Tryngolza cleared for FCS
BioWorld
Ionis Pharmaceuticals Inc. CEO Brett Monia predicted that diagnoses of familial chylomicronemia syndrome (FCS) will “accelerate fairly quickly” now that the firm...
NRP1 is NGF/TrkA partner in crime in pain signaling
BioWorld Science
Chronic pain affects about 20% of the population worldwide. It is – inadequately – treated with nonsteroidal anti-inflammatory compounds and opioids that lack...
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.